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Sudden unexpected death in infancy 
SUDI 
Sudden infant death syndrome 
SIDS 
A B S T R A C T   
Child mortality is a major health concern worldwide with over 4.2 million infants dying before reaching the age 
of one year in 2016 alone. Several international intervention initiatives have resulted in a decrease in the number 
of infant deaths; however, the incidence of sudden unexpected death in infancy (SUDI) and sudden infant death 
syndrome (SIDS) remain unacceptably high. SIDS still accounts for approximately 50–80% of SUDI cases, fol-
lowed by infection. 
The aim of this study was to investigate a selection of immune biomarkers that are associated with an immune 
response in an effort to support the diagnosis of an infectious cause (“Infection”) e.g. bronchopneumonia, 
interstitial pneumonitis, etc., instead of SIDS in SUDI cases. C-reactive protein and 18 different cytokines were 
retrospectively quantified in serum collected during post-mortem investigations of SUDI cases admitted to the 
Tygerberg Medico-legal Mortuary in the Western Cape Province of South Africa between 2015 and 2017. Sta-
tistical comparison was done between infants with a final cause of death (COD) of Infection and SIDS to inves-
tigate any correlations between the immune markers and sociodemographic information of the groups. A p-value 
of < 0.0026, after Bonferroni correction for multiple comparisons, was considered as statistically significant. 
A total of 169 cases were included, of which 65 (38.5%) were assigned a cause of death of Infection and 104 
(61.5%) SIDS by forensic pathologists. The male to female ratio of the entire group was 1:0.97 and the median 
age at the time of death was 9 (interquartile range [IQR] 10.9) weeks. The majority (56.8%) of deaths occurred 
during the colder seasons (autumn and winter) and the median post-mortem interval was 4 (IQR 3) days. 
No statistically significant differences were demonstrated for gender, season, sleeping position or bed-sharing 
between the Infection and SIDS groups. Age and interleukin-1α were identified as predictors of a COD of Infection 
before adjusting for the multiple comparisons problem. C-reactive protein was a statistically significant predictor 
of a COD of Infection even after adjusting for the effect of multiple comparisons. 
The COD is primarily based on histopathology of the lungs, where other causes of interstitial inflammation 
have been ruled out, and where there are morphological changes present suggestive of infection, but not enough 
evidence to assign a final COD of Infection, the cases are concluded as SIDS. These biomarkers can therefore be 
valuable in the investigation protocol of SUDI cases to increase the number Infection cases where the histopa-
thology of the lungs is suggestive of, but does not support conclusive evidence of infection.   
1. Introduction 
Sudden unexpected death in infancy (SUDI), where no cause of death 
(COD) is apparent, includes all infants who die unexpectedly under the 
age of one year, where fatal injury can be excluded before any 
investigations had been done to find a COD. A diagnosis of sudden infant 
death syndrome (SIDS) is made when the COD remains unexplained 
after a thorough medico-legal investigation (i.e. complete autopsy, re-
view of clinical history and in-depth death scene investigation) [18]. 
Globally, SIDS is still confirmed to be the COD for up to 80% of SUDI 
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cases [17,20] and although exact figures for South Africa are extremely 
scarce, Cape Town has been reported to have one of the highest SIDS 
rates in the world, with an incidence of up to 3.41/1 000 live births 
depending on the population group [7,25]. 
Several risk factors have been confirmed for SIDS and cases without 
risk factors are fairly uncommon [16]. The Triple Risk Model [8] de-
scribes the highest risk for SUDI in infants with latent biological vul-
nerabilities (e.g. prematurity, low birth weight, etc.), exposed to 
external threats or stressors (e.g. sleeping position, exposure to harmful 
substances, viral or bacterial infection, etc.) during a critical develop-
ment period (e.g. young age). 
Risks associated with SUDI include both sociodemographic (e.g. poor 
antenatal care, prematurity, low birth weight, young mothers with 
limited education, low socioeconomic status, colder seasons, male 
gender, a family history of SUDI, etc.) and modifiable factors (exposure 
to cigarette smoke, maternal drug and alcohol use, sleep-related factors, 
etc.) [5,12,17,26]. 
Despite several campaigns to modify the sleeping environment and 
educate parents about appropriate immunizations and infant care [4] 
the incidence of SUDI remains unacceptably high. Bed-sharing between 
infant(s) and adult(s) is still common practice in many populations [7] 
and although it promotes the spirit of Ubuntu (an indigenous African 
culture of universal human interdependence, solidarity and commu-
nalism) [11], it also increases the risk for SUDI. Prone sleeping is asso-
ciated with thermal stress, possible airway compression or collapse and 
re-breathing of exhaled gases [6,13]. It also enhances ingestion or 
inhalation of bacteria on contaminated sleeping surfaces, such as mat-
tresses, beds, sofas, etc. [14]. 
Antemortem respiratory infection symptomatology is common in 
cases of SIDS. Correspondingly, respiratory inflammatory changes are 
also quite often present in SIDS cases. Despite this, it has to be conceded 
that the degree of inflammatory change in the lungs as an indicator for 
pathology in SIDS deaths remain controversial [19]. Furthermore, pul-
monary interstitial inflammation is by no means indicative solely of the 
presence of an infective agent in the lungs. The list of causes of inter-
stitial inflammation/pneumonitis in infants is extensive, and forensic 
pathologists must carefully consider all information in a case to try to 
exclude other, non-infective causes of interstitial pneumonitis, before 
concluding that the COD is most likely an infection of the lungs. This 
includes, but is not limited to a detailed scene investigation, parental 
interview, environmental analysis and ancillary tests at autopsy. It is by 
no means an exact science. 
Respiratory and cardiovascular disorders specific to the perinatal 
period, followed by Influenza and pneumonia have consistently been 
found to represent the leading cause for all infant deaths in South Africa 
[30]. Feedback mechanisms in the South African Forensic Pathology 
Service are often found lacking for various reasons – the vast size of 
pathology office drainage areas, lack of telecommunication methods, 
etc., so the Forensic Pathologist often does not have the privilege of 
repeated contact with the parents of a deceased child. It is therefore of 
crucial importance, in the interest of health impact strategies, and the 
clear and succinct communication of the COD to bereaved parents, for 
the forensic pathologist to categorize infection-related deaths clearly 
and as early in the examination of the case as possible, based on the 
findings. 
Respiratory tract infections often present with blocked nasal pas-
sages, swollen mucous membranes, fever and increased oropharyngeal 
temperatures. This creates an ideal environment for Staphylococcus 
aureus, Escherichia coli and clostridia colonization, resulting in the 
release of staphylococcal and other interferon (IFN)-γ stimulating bac-
terial toxins [2,16,33]. Respiratory tract colonization by coliforms can 
increase the risk of SUDI by as much as 29 times. Viral and bacterial co- 
infections also dramatically exacerbate the clinical effect, with non- 
pathogenic commensal organisms being suspected of having a lethal 
effect in a susceptible infant [14]. 
Lower respiratory tract infections in infants are less common than 
upper respiratory tract infections, but have a higher morbidity and 
mortality [21]. Inflammatory changes in both upper and lower respi-
ratory tracts of SUDI cases are often found during the post-mortem in-
vestigations and symptoms suggestive of respiratory infection in the 
days preceding death are commonly reported [2,12]. 
Different viruses have been detected in the respiratory tract of SUDI 
cases, but the presence or severity of clinical symptoms cannot be 
associated with a specific virus. Asymptomatic viruses may cause min-
imal clinical manifestations in infants, but it can lead to unregulated 
expression of inflammatory mediators, or a “cytokine storm” that might 
lead to sudden death [2,23,28]. 
Cytokines can be regarded as useful biomarkers of infection because 
it represents an early component of the host response to the presence of 
infection [9]. When the homeostasis of the body is disturbed, e.g. as a 
result of an infection, the release of acute phase proteins triggers a non- 
specific innate response, followed by the production and release of pro- 
inflammatory cytokines at the site of infection or injury and activation of 
the vascular system and inflammatory cells [15]. Immune dysregulation 
also increases the vulnerability of an infant and significant associations 
have been described between SUDI cases and polymorphisms of the 
regulatory genes of the immune system, such as interleukin (IL)-1α, IL-6, 
IL-10, tumour necrosis factor (TNF)-α and IFN-γ [14,16]. These and 
other cytokines have been correlated with lung damage and clinical 
outcome, and the balance between pro- and anti-inflammatory cyto-
kines is important in immune modulation and the resolution of upper 
and lower respiratory tract infections [9]. IL-6 production is stimulated 
by the presence of bacteria and viruses, which induces fever and may 
affect the respiration of infants, increasing the frequency of apnoea. 
Inhibition of pro-inflammatory cytokines by IL-10 may clinically lead to 
hypoxaemia, hypoxia and ultimately death. However, IL-10 production 
can be inhibited by environmental factors, such as smoking, where 
nicotine can interfere with normal autoresuscitation after apnoea. The 
risk for SUDI is dramatically increased if this is accompanied by 
increased IL-1β production as part of an inflammatory response [33]. 
C-reactive protein (CRP) is an acute phase protein commonly used as 
a non-specific biomarker of infection and inflammation. It has been 
shown to be a valuable marker of infection in post-mortem samples 
[3,10,24,27]. However, very few studies have investigated any immune 
biomarkers as indicators of infection in SUDI and SIDS cases [34]. 
This study compared levels of specific immune biomarkers of 
inflammation in SUDI cases with a final COD of Infection and SIDS. In-
dividual or combinations of biomarkers were also evaluated as possible 
predictors of infection to supplement histopathological analysis of the 
lungs in SUDI cases in order to assign a final COD. 
2. Materials and methods 
The Health Research Ethics Committee of Stellenbosch University 
approved the study before sample collection commenced (number N12/ 
02/007). Anonymity and confidentiality were ensured by de- 
identification and only using the death register and unique study 
numbers of the cases. A waiver of consent was granted for this study, as 
collection, analysis and storage of specimens were performed according 
to the procedures set out in the Inquests and Criminal Procedures Acts 
(58 of 1959 and 51 of 1977 respectively). 
A total of 169 cases admitted to Tygerberg Medico-legal Mortuary 
between 2015 and 2017 were included. All cases fit the criteria for SUDI 
(i.e. infants aged between seven days and one year who died suddenly 
and unexpectedly without a pre-existing medical condition or apparent 
cause). Blood was directly collected from the heart during the autopsy, 
centrifuged to separate the serum from the red blood cells and stored at 
− 80 ◦C until the day of analysis. 
A customized ProcartaPlex™ Multiplex Immunoassay was used to 
quantify IL-1α , IL-1β, IL-1RA, IL-2, IL-4, IL-5, IL-6, IL-8, IL-12, IL-18, IL- 
23, IFN-α , IFN-γ, macrophage inflammatory protein (MIP)-1α , MIP-1β, 
TNF-α and IFN-γ induced protein (IP)-10 (pg/ml). Standards and 
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samples were analyzed in duplicate and results were interpreted with 
the ProcartaPlexTM Analyst Software. 
DRG® CRP High Sensitivity and Elabscience® Human ELISA kits 
were used to quantify CRP and IL-10 respectively (pg/ml). All samples 
were analyzed in duplicate according to the manufacturers’ instructions. 
Tissue sections from the lungs were collected, processed and stained 
with haematoxylin and eosin (H&E) to facilitate histologic evaluation 
with light microscopy. A variety of characteristics, including oedema, 
congestion, interstitial pneumonitis, bronchopneumonia, focal collapse, 
the presence of formalin or iron pigment, alveolar debris, alveolar 
haemorrhage and bronchiolitis were noted for each slide. Interstitial 
pneumonitis of grade 3 (moderate: diffuse involvement and associated 
with interstitial oedema), and higher [19] was considered supportive of 
a final COD of Infection, where other causes of interstitial pneumonitis 
were ruled out as far as possible (Fig. 1). 
As part of the medico-legal investigation, a questionnaire was 
completed by the parents or caregivers at the time the infant is admitted 
to the Tygerberg Medico-legal Mortuary. Sociodemographic details, 
clinical history of the infant and known risk factors for SUDI were 
captured. 
Logistic regression model was fitted to investigate associations be-
tween the COD and immune biomarkers, as well as specific socio-
demographic risk factors according to the literature. A p-value of 
<0.0026, after Bonferroni correction for multiple comparisons, was 
considered as statistically significant. 
3. Results 
The study group comprised a male to female ratio of 1:0.97 with a 
median age at the time of death of 9 (interquartile range [IQR] (5.55, 
16.425)) weeks. The Infection and SIDS subgroups included 65 (38.5%) 
and 104 (61.5%) cases respectively. Overall, the majority (56.8%) of 
deaths occurred during the colder seasons (autumn and winter) and the 
median post-mortem interval (PMI) was 4 (IQR (3, 6)) days. 
Details on the sleeping position of the infants were recorded for 146 
of the 169 cases. Despite several awareness campaigns on the dangers of 
the prone sleeping position, the majority still slept on their stomachs or 
sides (44.5% and 47.3% respectively). Information on bed-sharing was 
available in 150 cases and the vast majority (95.3%) confirmed bed- 
sharing between the infant and other family members. Informal hous-
ing, as defined as a structure built with scrap material or small dwellings 
which house more than 10 people [7] was reported in more than half of 
the study group (55.9%). 
The presence of clinical symptoms prior to death was positively 
associated with sleeping position, bed-sharing, ventilation and housing. 
Younger age was significantly associated with the Infection group and 
can be regarded as a predictor for Infection (p = 0.012), before adjusting 
for effect of other confounders. Although marginally more males than 
females presented as SUDI during the study period, no significant dif-
ferences could be demonstrated between gender and any of the 
variables. 
4. Immune markers 
All immune marker results were reported in pg/ml. In the crude 
analysis, statistically higher IL-1RA levels were found in cases during the 
warmer season compared to the colder season (p < 0.0001). IL-1α and 
CRP levels were significantly higher in the Infection than SIDS groups (p 
= 0.028 and 0.001 respectively), while IL-2 and IL-4 levels were 
significantly lower in the Infection than SIDS groups (p = 0.009 and 
0.039 respectively). An increase of 1 pg/ml in CRP and IL-1α levels 
decreased the odds of COD of Infection by 11.2% and 0.8%, compared to 
SIDS groups respectively. An increase of 1 pg/ml in IL-2 and IL-4 levels 
increased the odds of COD of Infection by 0.2% and 0.8%, compared to 
SIDS groups respectively. No other statistical significance could be 
demonstrated between COD and any of the biomarkers (Table 1). 
CRP levels was significantly higher in the Infection than SIDS groups 
(p = 0.001, after adjusting for multiple comparisons). 
5. Discussion 
Male gender has consistently been reported as a risk factor for SUDI. 
An extensive review of infant deaths between 1968 and 2010 from data 
released by the Centre for Disease Control and Prevention (CDC) also 
Fig. 1. Haematoxylin and eosin stained lung tissue displaying Grade 3 interstitial pneumonitis (200x magnification) with thickening of the alveolar walls and areas 
of alveolar collapse, as well as a thickened and hypercellular interstitium. The interstitium is expanded by mononuclear inflammatory cells, such as lymphocytes or 
macrophages. 
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showed a male predominance of 60% and 61% in cases of acute respi-
ratory infections and respiratory distress syndrome respectively [22]. 
However, statistical analysis in the current study did not demonstrate 
any significance for gender, and in fact found a lower percentage of 
males in the Infection group than SIDS (45% and 55% respectively). 
Previous SUDI studies at the Tygerberg Medico-legal Mortuary have also 
produced variation in male-to-female ratios over time (data not shown) 
and it is postulated that sociodemographic and other factors, such as 
temperature, rainfall, access to water and sanitation, the presence of co- 
morbidities, etc. could contribute towards these discrepancies. 
SUDI is a multifactorial phenomenon and it is clear that infection is 
one of the major contributors. Acute phase reaction to infection is 
characterized by IL-1β and IL-6 production, followed by CRP synthesis in 
the liver and release into the circulation. CRP starts increasing within 6 h 
of the onset of infection, reaches a peak around 48 h post-infection [10] 
but can remain increased for up to 6 days after death [32]. 
As expected, CRP and IL-1α were significantly increased in the 
Infection group as a result of an immune response possibly due to viral or 
bacterial infection. However, IL-6 levels in this group were increased, 
but not significantly different from the SIDS group. It is unlikely that this 
was due to the PMI, because it was well within the reported period of 
stability [32]. Although these are non-specific markers which cannot 
identify the exact causative pathogen or location, it can confirm the 
presence of infection [3,10]. 
The association between season and cytokine expression is an 
evolving field. While environmental and host factors have been reported 
to affect the immune response in healthy adults, very little is known in 
infants. It is also possible that variation in cytokine expression can be 
associated with known seasonality of infectious diseases, e.g. influenza 
[1,29,31]. Although this study identified a significant seasonal associ-
ation in IL-1RA expression, the clinical, pathological and physiological 
relevance is not clear. The small sample size also does not allow for 
extrapolation to the general paediatric and / or SUDI populations. 
In the Western Cape Province of South Africa, the Tygerberg Medico- 
legal Mortuary institutional protocol and Department of Health budget 
does not provide for molecular identification of specific viruses, mainly 
due to the high cost involved in these tests. The gold standard for 
diagnosing an infection in SUDI cases remains histological evaluation 
and in many cases there is suggestive, but inconclusive evidence to 
confirm Infection as the final COD. These cases are regarded as Borderline 
SIDS and then assigned a final COD of SIDS. However, if the levels of 
biomarkers indicative of inflammation, such as CRP, IL-1α and IL-6, are 
increased in these borderline cases where moderate histological changes 
are present, it could provide more conclusive evidence of infection and 
the COD could be amended to Infection rather than SIDS. 
6. Conclusion 
This study did not include any analysis to identify specific viral or 
bacterial infections, but CRP, IL-1α and IL-6 were useful biomarkers to 
suggest infection in the absence of discriminatory tests. It can be valu-
able if used in combination with histological analysis to increase the 
number of cases in the presence of infection to be correctly classified as 
Infection. 
However, not all the information was available for all the cases due 
to incomplete questionnaires, and this data could be subject to recall 
bias. 
Declaration of Competing Interest 
The authors declare that they have no known competing financial 
interests or personal relationships that could have appeared to influence 
the work reported in this paper. 
Acknowledgement 
Funding: This work was supported by the South African Medical 
Research Council (Self-Initiated Research Grant Nr 47881), National 
Health Laboratory Service Research Trust (Development Grants Nrs 
94207 and 94380), Poliomyelitis Research Foundation (Student bur-
saries, Grant Nrs 12/06 and 15/07) and National Research Foundation 
(Internship). 
Ms Danielle Cupido, Mr Don Matshazi and Ms Christine Evert assis-
ted with the laboratory assays. 
References 
[1] R. Aguirre-Gamboa, I. Joosten, P.C.M. Urbano, et al. Differential effects of 
environmental and genetic factors on T and B cell immune traits. Cell Rep. 17 (9) 
(2016) 2474–2487. doi:10.1016/j.celrep.2016.10.053. 
[2] M. Alfelali, G. Khandaker, Infectious causes of sudden infant death syndrome, 
Paediatr. Resp. Rev. 15 (4) (2014) 307–311, https://doi.org/10.1016/j. 
prrv.2014.09.004. 
[3] B.S. Astrup, J.L. Thomsen, The routine use of C-reactive protein in forensic 
investigations, Forensic Sci. Int. 172 (1) (2007) 49–55, https://doi.org/10.1016/j. 
forsciint.2006.10.021. 
[4] E. Athanasakis, S. Karavasiliadou, I. Styliadis, The factors contributing to the risk of 
sudden infant death syndrome, Hippokratia 15 (2) (2011) 127–131. PubMed PMID: 
22110293. 
[5] P.S. Blair, P.J. Fleming, D. Bensley, I. Smith, C. Bacon, E. Taylor, J. Berry, J. 
Golding, J. Tripp, Confidential Enquiry into Stillbirths and Deaths Regional 
Coordinators and Researchers. Smoking and the sudden infant death syndrome: 
results from the 1993-5 case-control inquiry into stillbirths and deaths in infancy. 
Confidential Enquiry into Stillbirths and Deaths Regional Coordinators and 
Researchers. BMJ 313(7051) (1996) 195–198. doi:10.1136/bmj.313.7051.195. 
Table 1 
Comparison of immune biomarkers and cause of death.  
Biomarker Cause of Death 
(n) 
Crude Odds 
Ratio (95% CI) 
Adjusted Odds 



































































































*Adjusted for effects of gender, season and age. 
C. de Beer et al.                                                                                                                                                                                                                                 
Downloaded for Anonymous User (n/a) at Stellenbosch University from ClinicalKey.com by Elsevier on March 30, 2021.
For personal use only. No other uses without permission. Copyright ©2021. Elsevier Inc. All rights reserved.
Human Pathology: Case Reports 23 (2021) 200477
5
[6] R. Carpenter, C. McGarvey, E.A. Mitchell, D.M. Tappin, M.M. Vennemann, 
M. Smuk, R.J. Carpenter, Bed sharing when parents do not smoke: is there a risk of 
SIDS? An individual level analysis of five major case-control studies, BMJ Open 3 
(5) (2013) 1–11, https://doi.org/10.1136/bmjopen-2012-02299. 
[7] J.J. Dempers, J. Coldrey, E.H. Burger, V. Thompson, S.A. Wadee, H.J. Odendaal, M. 
A. Sens, B.B. Randall, R.D. Folkerth, H.C. Kinney, The institution of a standardized 
investigation protocol for sudden infant death in the eastern metropole, Cape 
Town, South Africa, J. Forensic Sci. 61 (6) (2016) 1508–1514. 
[8] J.J. Filiano, H.C. Kinney, A perspective on neuropathologic findings in victims of 
the sudden infant death syndrome, Biol. Neonate 65 (1994) 194–197, https://doi. 
org/10.1159/000244052. 
[9] A. Fuchs, V. Gotta, M.-L. Decker, G. Szinnai, P. Baumann, J. Bonhoeffer, N. Ritz, 
G. Baer, G. Berthet, J.M. Bonhoeffer, M. Buettcher, M. Gambon, U. Heininger, 
B. Mueller, U.B. Schaad, P. Schuetz, D. Trachsel, Cytokine kinetic profiles in 
children with acute lower respiratory tract infection: a post hoc descriptive analysis 
from a randomized control trial, Clin. Microbiol. Infect. 24 (12) (2018) 1341. 
e1–1341.e7, https://doi.org/10.1016/j.cmi.2018.03.016. 
[10] M.Q. Fujita, B.-L. Zhu, K. Ishida, L.i. Quan, S. Oritani, H. Maeda, Serum C-reactive 
protein levels in postmortem blood—an analysis with special reference to the cause 
of death and survival time, Forensic Sci. Int. 130 (2-3) (2002) 160–166, https:// 
doi.org/10.1016/s0379-0738(02)00381-x. 
[11] C.B.N. Gade, What is Ubuntu? Different interpretations among South Africans of 
African descent, S. Afr. J. Philos. 31 (3) (2012) 484–503, https://doi.org/10.1080/ 
02580136.2012.10751789. 
[12] B.C. Galland, D.E. Elder, Sudden unexpected death in infancy: Biological 
Mechanisms, Paediatr. Resp. Rev. 15 (2014) 287–292, https://doi.org/10.1016/j. 
prrv.2014.09.003. 
[13] A.J. Garcia III, J.E. Koschnitzky, J.-M. Ramirez, The physiological determinants of 
Sudden Infant Death Syndrome, Respir. Physiol. Neurobiol. 189 (2) (2013) 
288–300, https://doi.org/10.1016/j.resp.2013.05.032. 
[14] P.N. Goldwater, Infection: the neglected paradigm in SIDS research, Arch. Dis. 
Child 102 (8) (2017) 767–772, https://doi.org/10.1136/archdischild-2016- 
312127. 
[15] E. Gruys, M.J.M. Toussaint, T.A. Niewold, S.J. Koopmans, Acute phase reaction and 
acute phase proteins, J. Zhejiang Univ. Sci. 6B (11) (2005) 1045–1056. 
[16] A. Hafke, P. Schürmann, T. Rothämel, T. Dörk, M. Klintschar, Evidence for an 
association of interferon gene variants with sudden infant death syndrome, Int. J. 
Legal Med. 133 (3) (2019) 863–869, https://doi.org/10.1007/s00414-018-1974-6. 
[17] H.C. Kinney, B.T. Thach, The sudden infant death syndrome. N. Engl. J. Med. 361 
(8) (2009) 795–805. doi:10.1056/NEJMra0803836. 
[18] H.F. Krous, J.B. Beckwith, R.W. Byard, T.O. Rognum, T. Bajanowski, T. Corey, 
E. Cutz, R. Hanzlick, R.G. Keens, E.A. Mitchell, Sudden infant death syndrome and 
unclassified sudden infant deaths: A definitional and diagnostic approach, 
Pediatrics 114 (1) (2004) 234–238, https://doi.org/10.1542/peds.114.1.234. 
[19] H.F. Krous, J.M. Nadeau, P.D. Silva, B.D. Blackbourne, A comparison of respiratory 
symptoms and inflammation in sudden infant death syndrome and in accidental or 
inflicted infant death, Am. J. Forensic Med. Pathol. 24 (1) (2003) 1–8, https://doi. 
org/10.1097/01.PAF.0000051520.92087.C3. 
[20] H. la Grange, J. Verster, J.J. Dempers, C. de Beer, Review of immunological and 
virological aspects as contributory factors in Sudden Unexpected Death in Infancy 
(SUDI), Forensic Sci. Int. 245 (2014) 12–16, https://doi.org/10.1016/j. 
forsciint.2014.09.022. 
[21] M. Loeffelholz, T. Chonmaitree, Advances in Diagnosis of Respiratory Virus 
Infections, Int. J. Microbiol. 2010 (2010) 126049, https://doi.org/10.1155/2010/ 
126049. 
[22] D.T. Mage, E.M. Donner, Is excess male infant mortality from sudden infant death 
syndrome and other respiratory diseases X-linked? Acta Paediatr. 103 (2014) 
188–193, https://doi.org/10.1111/apa.1248. 
[23] G.A. Melendi, F.R. Laham, A.C. Monsalvo, J.M. Casellas, V. Israele, N.R. Polack, S. 
R. Kleeberger, F.P. Polack, Cytokine profiles in the respiratory tract during primary 
infection with human metapneumovirus, respiratory syncytial virus, or influenza 
virus in infants, Pediatrics 120 (2) (2007) e410–e415. 
[24] S. Mimasaka, Postmortem cytokine levels and the cause of death. Tohoku J. Exp. 
Med. 197(3) (2002) 145–150. doi:10.1620/tjem.197.145. 
[25] C.D. Molteno, E. Ress, M.A. Kibel, Early childhood mortality in Cape Town, S. Afr. 
Med. J. 75 (1989) 570–572. PubMed PMID: 2727857. 
[26] S.M. Moscovis, S.T. Hall, C.J. Burns, R.J. Scott, C.C. Blackwell, The male excess in 
sudden infant deaths, Innate Immun. 20 (1) (2014) 24–29, https://doi.org/ 
10.1177/1753425913481071. 
[27] J. Qu, Z. Lü, Y. Liu, X. Wang, Evaluation of procalcitonin, C-reactive protein, 
interleukin-6 & serum amyloid A as diagnostic biomarkers of bacterial infection in 
febrile patients, Indian J. Med. Res. 141 (3) (2015) 315–321, https://doi.org/ 
10.4103/0971-5916.156617. 
[28] M.W. Raza, C.C. Blackwell, Sudden infant death syndrome, virus infections and 
cytokines. FEMS Immunol. Med. Microbiol. 25(1–2) (1999) 85–96. doi:10.1111/ 
j.1574-695X.1999.tb01330.x. 
[29] P. Spath, V. Tisato, S. Geianesini, et al. The calendar of cytokines: Seasonal 
variation of circulating cytokines in chronic venous insufficiency. JRSM 
Cardiovasc. Dis, 6 (2017) 2048004017729279. 10.1177/2048004017729279. 
[30] StatsSA. Mortality and causes of death in South Africa: Findings from death 
notifications, 2017. Available at http://www.statssa.gov.za/publications/P03093/ 
P030932017.pdf. 
[31] R. Ter Horst, M. Jaeger, S.P. Smeekens, et al. Host and environmental factors 
influencing individual human cytokine responses. Cell 167 (2016) 1111–1124. doi: 
10.1016/j.cell.2016.10.018. 
[32] L. Uhlin-Hansen, C-reactive protein (CRP), a comparison of pre- and post-mortem 
blood, Forensic Sci. Int. 124 (2001) 32–35, https://doi.org/10.1016/s0379-0738 
(01)00558-8. 
[33] Å. Vege, T.O. Rognum, Sudden infant death syndrome, infection and inflammatory 
responses, FEMS Immunol. Med. Microbiol. 42 (2004) 3–10, https://doi.org/ 
10.1016/j.femsim.2004.06.015. 
[34] M.M.T. Vennemann, B. Loddenkötter, T. Fracasso, E.A. Mitchell, A.S. Debertin, K. 
P. Larsch, J.P. Sperhake, B. Brinkmann, C. Sauerland, M. Lindemann, 
T. Bajanowski, Cytokines and sudden infant death, Int. J. Legal Med. 126 (2) 
(2012) 279–284, https://doi.org/10.1007/s00414-011-0638-6. 
C. de Beer et al.                                                                                                                                                                                                                                 
Downloaded for Anonymous User (n/a) at Stellenbosch University from ClinicalKey.com by Elsevier on March 30, 2021.
For personal use only. No other uses without permission. Copyright ©2021. Elsevier Inc. All rights reserved.
